gamma-aminobutyric acid has been researched along with Fatty Liver with Encephalopathy in 14 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Elevated serum levels of gamma-aminobutyric acid (GABA), a potent inhibitory neurotransmitter, have recently been implicated in the pathogenesis of hepatic encephalopathy." | 3.67 | Elevated serum gamma-aminobutyric acid levels in children with Reye's syndrome. ( Buchan, K; Minuk, GY; Sarjeant, EJ, 1985) |
| "The mean serum GABA level for the Reye's syndrome group (3." | 1.27 | Elevated serum gamma-aminobutyric acid levels in children with Reye's syndrome. ( Buchan, K; Minuk, GY; Sarjeant, EJ, 1985) |
| "[3H]GABA binding (IC50) was altered in Huntington's chorea and Reye's syndrome, but not in schizophrenics (4-neuroleptic-treated patients) or sudden infant death syndrome." | 1.26 | An analysis of [3H]gamma-aminobutyric acid (GABA) binding in the human brain. ( Dreksler, S; Lloyd, KG, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (64.29) | 18.7374 |
| 1990's | 5 (35.71) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, B | 1 |
| Sugimoto, T | 1 |
| Yasuhara, A | 1 |
| Nishida, N | 1 |
| Sakane, Y | 1 |
| Sugimoto, Y | 1 |
| Noda, S | 2 |
| Lloyd, KG | 1 |
| Dreksler, S | 1 |
| Matsumoto, M | 2 |
| Kuhara, T | 3 |
| Inoue, Y | 2 |
| Shinka, T | 3 |
| Matsumoto, I | 2 |
| Shimizu, S | 1 |
| Miura, M | 1 |
| Kawaguchi, T | 1 |
| Nakamura, Y | 1 |
| Takei, M | 1 |
| Miyahara, H | 1 |
| Furuta, K | 1 |
| Sodeyama, T | 1 |
| Kiyosawa, K | 1 |
| Furuta, S | 1 |
| Kajita, M | 1 |
| Watanabe, R | 1 |
| Ohsuga, S | 1 |
| Ohsuga, H | 1 |
| Takeoka, T | 1 |
| Ikeda, A | 1 |
| Shinohara, Y | 1 |
| Itagaki, T | 1 |
| Hishimura, M | 1 |
| Hatta, M | 1 |
| Takenaka, H | 1 |
| Yoshida, R | 1 |
| Yasuhara, O | 1 |
| Urushibara, A | 1 |
| Umezaki, H | 1 |
| Yamamoto, K | 1 |
| Araki, T | 1 |
| Murakami, T | 1 |
| Ishii, N | 1 |
| Kimura, A | 1 |
| Yoshida, I | 1 |
| Ono, E | 1 |
| Matsuishi, T | 1 |
| Yoshino, M | 1 |
| Yamashita, F | 1 |
| Yamamoto, M | 1 |
| Hashimoto, T | 1 |
| Izumi, T | 1 |
| Utsumi, H | 1 |
| Osawa, M | 1 |
| Fukuyama, Y | 1 |
| Minuk, GY | 1 |
| Sarjeant, EJ | 1 |
| Buchan, K | 1 |
1 review available for gamma-aminobutyric acid and Fatty Liver with Encephalopathy
| Article | Year |
|---|---|
[Delayed type malignant syndrome and Parkinson's syndrome due to tiapride, Reye-like syndrome induced by calcium hopantenate].
Topics: Animals; Antipsychotic Agents; Diagnosis, Differential; gamma-Aminobutyric Acid; Humans; Neuroleptic | 1999 |
13 other studies available for gamma-aminobutyric acid and Fatty Liver with Encephalopathy
| Article | Year |
|---|---|
A proposed therapy for the encephalopathies of Reye's syndrome and hepatic encephalopathy.
Topics: Animals; Benzodiazepines; gamma-Aminobutyric Acid; Hepatic Encephalopathy; Humans; Rabbits; Receptor | 1984 |
[3 cases of acute encephalopathy associated with calcium hopantenate administration].
Topics: Acute Disease; Child, Preschool; Female; gamma-Aminobutyric Acid; Humans; Infant; Intellectual Disab | 1983 |
An analysis of [3H]gamma-aminobutyric acid (GABA) binding in the human brain.
Topics: Adolescent; Adult; Aged; Binding Sites; Binding, Competitive; Brain; Caudate Nucleus; Cerebellar Cor | 1979 |
Abnormal fatty acid metabolism in patients in hopantenate therapy during clinical episodes.
Topics: Acids; Aged; Child, Preschool; Fatty Acids; Female; gamma-Aminobutyric Acid; Gas Chromatography-Mass | 1991 |
[A case of Reye's syndrome occurred during administration of calcium hopantenate].
Topics: Biopsy; Female; gamma-Aminobutyric Acid; Humans; Liver; Middle Aged; Pantothenic Acid; Reye Syndrome | 1990 |
Mass spectrometric identification of 2-hydroxydodecanedioic acid and its homologues in urine from patients with hopantenate therapy during clinical episode.
Topics: Aged; Child, Preschool; Dicarboxylic Acids; Female; gamma-Aminobutyric Acid; Gas Chromatography-Mass | 1990 |
[Consciousness disorders in the aged due to therapeutic drugs].
Topics: Aged; Anemia; Cognition Disorders; Consciousness Disorders; Drug Interactions; Flunarizine; gamma-Am | 1990 |
[Metabolic acidosis and hypoglycemia during calcium hopantenate administration--report on 5 patients].
Topics: Acidosis, Lactic; Aged; Aged, 80 and over; Female; gamma-Aminobutyric Acid; Humans; Hypoglycemia; Ma | 1989 |
[The relationship between the physical features and medications in Reye-like syndrome in elderly patients].
Topics: Aged; Aged, 80 and over; Brain; Female; gamma-Aminobutyric Acid; Humans; Hypoglycemia; Male; Pantoth | 1989 |
Reye-like syndrome following treatment with the pantothenic acid antagonist, calcium hopantenate.
Topics: Aged; Biopsy; Dementia; Female; gamma-Aminobutyric Acid; Humans; Liver; Microscopy, Electron; Pantot | 1988 |
Acute encephalopathy with hyperammonemia and dicarboxylic aciduria during calcium hopantenate therapy: a patient report.
Topics: Acute Disease; Ammonia; Brain Diseases; Child, Preschool; Female; gamma-Aminobutyric Acid; Humans; P | 1986 |
[A clinico-biochemical study of acute encephalopathy in patients treated with Ca-hopantenate].
Topics: Acute Disease; Adolescent; Adult; Age Factors; Blood Chemical Analysis; Brain Diseases; Child; Child | 1985 |
Elevated serum gamma-aminobutyric acid levels in children with Reye's syndrome.
Topics: Child; Child, Preschool; Female; gamma-Aminobutyric Acid; Hepatic Encephalopathy; Hepatitis A; Hepat | 1985 |